Results 171 to 180 of about 58,075 (254)

Pulmonary Vascular Endothelial Cells in Lung Diseases: Mechanisms, Therapeutic Strategies, and Future Directions

open access: yesCell Proliferation, Volume 59, Issue 2, February 2026.
The pathogenic mechanisms of pulmonary vascular endothelial cells (VECs) in lung diseases and their multimodal therapeutic strategies. ABSTRACT Pulmonary vascular endothelial cells (VECs) are essential for the normal function of the lung, through maintaining vascular barrier integrity, regulating blood flow, and participating in inflammatory responses ...
Qianyue Liu   +5 more
wiley   +1 more source

Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications

open access: yesHepatology Research, Volume 56, Issue 2, Page 139-147, February 2026.
ABSTRACT Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease characterized by diverse clinical and histological manifestations. Accurate histopathological evaluation plays a critical role in determining disease activity, guiding treatment strategies, and predicting prognosis.
Mina Komuta, Kenichi Harada
wiley   +1 more source

Is there an alternative to the indirect immunofluorescence ANA HEp-2 assay for the diagnosis of connective tissue diseases? [PDF]

open access: yesFront Immunol
Hadjout T   +9 more
europepmc   +1 more source

Primary care in the United kingdom. [PDF]

open access: yes, 2008
Majeed, Azeem, Molokhia, Mariam
core   +1 more source

Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 228-240, February 2026.
Abstract Objectives Anti‐MDA5 dermatomyositis (anti‐MDA5 DM) is the most severe subtype of dermatomyositis, due to its pulmonary involvement. Current treatment involves corticosteroids and immunosuppressants, but variability in responses exists. This study aims to evaluate the efficacy and safety of Janus kinase (JAK)– and calcineurin–inhibitor ...
Valentine Pagis   +47 more
wiley   +1 more source

Systemic Sclerosis in Kazakh Patients: A Preliminary Case-Control Immunogenetic Profiling Study. [PDF]

open access: yesPathophysiology
Zaripova L   +5 more
europepmc   +1 more source

Never say never

open access: yes
Journal of Hospital Medicine, Volume 21, Issue 2, Page 200-204, February 2026.
Gurpreet Dhaliwal   +4 more
wiley   +1 more source

Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases

open access: yesNeuropathology, Volume 46, Issue 1, February 2026.
ABSTRACT Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES). Manifestations of stroke in HES have been described in the radiologic literature; however the pathologic characterization of central nervous system (CNS) involvement in HES is limited.
Karina C. Martin   +3 more
wiley   +1 more source

Lupus Enteritis: An Unusual Flare of Systemic Lupus Erythematosus. [PDF]

open access: yesCureus
Casanova Pinto J   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy